Literature DB >> 15358090

Crystal and molecular structure and absolute configuration of lincomycin hydrochloride monohydrate.

Manju Rajeswaran1, Thamarapu Srikrishnan.   

Abstract

Lincomycin is a broad-spectrum antibiotic synthesized by Streptomyces lincolnensis that is particularly active against Gram-positive bacteria. It is widely used in human and veterinary applications. The crystal structure of lincomycin has been undertaken with a view to obtain the conformational and structural features of the drug in order to afford a comparison of its structural features with other aminoglycoside antibiotics. We report here the details of its structural and conformational features as determined by single-crystal X-ray crystallography. Crystals of lincomycin hydrochloride are orthorhombic, space group P2(1)2(1)2, with the cell dimensions a=18.5294(3) Angstroms, b=20.5980(4) Angstroms, c=6.17380(10) Angstroms, V=2356.35(7) Angstroms3. The structure was solved using X-ray diffraction data and refined to a final R-value of 0.0391 for 2321 reflections (I > or = 2sigma). The absolute configuration was established using the anomalous dispersion of the sulfur and chlorine atoms in the structure. The molecule consists of an amino acid linked by an amide group to a monosaccharide of galactose stereochemistry. A network of hydrogen-bonds stabilizes the crystal structure.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15358090     DOI: 10.1016/j.carres.2004.05.032

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  2 in total

1.  Quantum mechanical studies of lincosamides.

Authors:  Katarzyna Kulczycka-Mierzejewska; Joanna Trylska; Joanna Sadlej
Journal:  J Mol Model       Date:  2011-11-25       Impact factor: 1.810

2.  Molecular dynamics simulations suggest why the A2058G mutation in 23S RNA results in bacterial resistance against clindamycin.

Authors:  Katarzyna Kulczycka-Mierzejewska; Joanna Sadlej; Joanna Trylska
Journal:  J Mol Model       Date:  2018-07-03       Impact factor: 1.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.